Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (1), 42-45
- https://doi.org/10.1016/s0015-0282(16)60425-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Comparison of a fixed and dynamic protocol for embryo replacement in an IVF/ET programmeHuman Reproduction, 1988
- Buserelin suppression of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatmentFertility and Sterility, 1988
- Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: an attenuated form of ovarian hyperstimulation syndromeFertility and Sterility, 1988
- Management of failed cycles in an IVF/GIFT programme with the combination of GnRH analogue and HMGHuman Reproduction, 1987
- Current treatments with LHRH and its analoguesHuman Reproduction, 1987
- Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical resultsFertility and Sterility, 1986
- Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophinsHuman Reproduction, 1986
- Ultrasonic assessment of subsequent unexplained infertility after ovulation inductionBJOG: An International Journal of Obstetrics and Gynaecology, 1983